April 7, 2014
by Endia Vereen
JURIST Guest Columnist Kristen Swift, Widener University School of Law Class of 2014, discusses Merck & Co.'s NuvaRing settlement and the company's corporate governance policies...Recently, Merck & Co. made a major splash across headlines by offering NuvaRing plaintiff's a $100 million ...[read more]
May 29, 2013
by Kyle Webster
On May 29, 1948, the United Nations Truce Supervision Organization (UNTSO) was founded by the UN Security Council through Resolution 50 with the goals of assisting with peace in the Middle East and responding to tensions that resulted from the founding of Israel. The UNTSO still exists today as ...[read more]
May 29, 2012
by Garrett Eisenhour
On May 29, 2008, a Texas state appeals court overturned a $26 million jury verdict against pharmaceutical giant Merck awarded to widow Carol Ernst, who alleged that her husband died after taking painkiller Vioxx. That same day, the New Jersey Appellate Division reduced a jury award in a separate ...[read more]
November 23, 2011
by Jamie Reese
Merck & Co reached a settlement agreement Tuesday with the US Department of Justice (DOJ), agreeing to pay $950 million in criminal and civil penalties. The agreement includes $321 million in criminal fines and $628 million in civil fines as well as submitting a guilty plea to an information ...[read more]
June 30, 2010
by Patrice Collins
A judge for the US District Court for the Eastern District of Louisiana on Tuesday ruled in favor of Merck & Co. in a lawsuit filed by the state of Louisiana over reimbursements for the prescription painkiller Vioxx. Louisiana had argued that it would have restricted the sales of Vioxx ...[read more]
April 27, 2010
by Jaclyn Belczyk
The US Supreme Court on Tuesday allowed a suit to proceed against drug maker Merck & Co. over the safety record of its painkiller Vioxx. The court ruled unanimously in Merck & Co. v. Reynolds that the statute of limitations in a securities fraud lawsuit begins to run once the plaintiff ...[read more]
April 27, 2010
by Jaclyn Belczyk
The US Supreme Court on Tuesday allowed a suit to proceed against drug maker Merck & Co. over the safety record of its painkiller Vioxx. The court ruled unanimously in Merck & Co. v. Reynolds that the statute of limitations in a securities fraud lawsuit begins to run once the plaintiff ...[read more]
November 30, 2009
by Jaclyn Belczyk
The US Supreme Court heard oral arguments Monday in two cases. In Graham County Soil & Water Conservation Dist. v. United States ex rel. Wilson, the Court heard arguments on the scope of the public disclosure jurisdictional bar of the False Claims Act, to determine if the Act allows federal ...[read more]
September 30, 2009
by JURIST Staff
On September 30, 2004, the pharmaceutical company, Merck, pulled its arthritis drug, Vioxx from the worldwide market, due to strokes and heart attacks in patients, but the move did not stop over 45,000 former-users and their families from suing Merck. The plaintiffs, however, have struggled to ...[read more]
May 26, 2009
by Andrew Morgan
The US Supreme Court on Tuesday granted certiorari in Merck & Co. v. Reynolds, in which the Court will decide when the statute of limitations begins to run in a securities fraud case under the inquiry notice standard. Investors brought a class action suit against the drug maker Merc... ...[read more]

Support JURIST

We rely on our readers to keep JURIST running

 Donate now!

© Copyright JURIST Legal News and Research Services, Inc., 2013.